Clinical TrialsSearch results
Number of results: 482
Other
- A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer.
- Non-small cell lung cancer
- Institute of Biomedical Research and Innovation
- 2005-09-08
Other
- Outcome study of complete resections for p-N2 non-small cell lung cancer
- non-small cell lung cancer
- JMTO
- 2008-07-28
Other
- Phase I/II study of intermittent erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer
- Non-small cell lung cancer
- West Japan Oncology Group
- 2009-03-17
Other
- phase II study of Erlotinib for non-small cell lung cancer patients with EGFR mutation
- non-small cell lung cancer
- Nagasaki Thoracic Oncology Group
- 2009-04-04
Other
- Subepithelial injection of botulinum toxin A for non-neurogecic overactive bladder
- Non-neurogenic overactive bladder
- National Center for Geriatrics & Gerontology
- 2008-10-14
Other
- Evaluate efficacy and safety of umbilical cord-derived mesenchymal stromal cells (HLC-001) for patient with Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
- Non-infectious Pulmonary Complications, Idiopathic Pneumonia Syndrome
- Morio Ikeda
- 2022-05-10
Other
- Gefitnib monotherapy in patients with post-operative recurrent non-small-cell lung cancer with the EGFR mutation: a Phase II study
- non small cell lung cancer with EGFR mutation
- Okayama University Cancer and Thoracic Surgery
- 2006-04-24
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Randomized phase II trial of gemcitabine(GEM) and carboplatin (CBDCA) with or without Dexamethasone(Dex) in untreated non-small cell lung cancer (NSCLC).
- Non small cell lung cancer
- Kyoto Thoracic Oncology Research Group (KTORG)
- 2007-01-01
Other
- Phase III Randomized Adjuvant Study of Chemotherapy in Node Positive Breast Cancer Patients -AC(Anthracycline-Cyclophosphamide) 4 cycles followed by Taxane 4 cycles (AC-Tac) versus Taxane 8 cycles and Paclitaxel versus Docetaxel-
- node positive breast cancer
- N-SAS BC 02 executive committee
- 2005-08-12